Methionine Sulfoxide Reductase Enzymes: A Possible Virulence Factor for the Management of Antibiotic Resistance Crisis in the Climate Change Era

Main Article Content

Cesare Achilli
Annarita Ciana
Giampaolo Minetti

Abstract

The problem of antibiotic resistance develops when bacteria are able to grow in the presence of conventional antimicrobial drugs and today represents a serious public health issue. The environmental effects of global warming, by unknown genomic mechanisms of adaption, could dramatically increase this phenomenon and support a more rapid progression to “post-antibiotic era”, in which common infections will be untreatable. Alternative approaches toward drug-resistant bacterial infections need to be explored to ensure effective therapies. Bacterial pathogens produce virulence factors that allow them to invade and to damage host cells. Methionine sulfoxide reductase (Msr) enzymes (MsrAs and MsrBs) are important, but poor studied, virulence factors for many bacterial strains. A deeper insight into their mechanism of action and regulation could help in developing novel therapeutic strategies toward drug-resistant bacteria, in order to overcome the antibiotic resistance crisis.

Keywords:
Antibiotic crisis, bacterial infection, global warming, methionine sulfoxide reductase, MsrA, MsrB, public health, virulence factor

Article Details

How to Cite
Achilli, C., Ciana, A., & Minetti, G. (2019). Methionine Sulfoxide Reductase Enzymes: A Possible Virulence Factor for the Management of Antibiotic Resistance Crisis in the Climate Change Era. International Journal of Environment and Climate Change, 9(8), 443-446. https://doi.org/10.9734/ijecc/2019/v9i830129
Section
Commentary

References

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT. 2015;40 (4):277-83.
Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/.

O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. HM Government and Wellcome Trust; 2014.
(Accessed: 19 May 2016)
Available: https://amr-review.org/.

Patz JA, Epstein PR, Burke TA, Balbus JM. Global climate change and emerging infectious diseases. JAMA. 1996;275 (3):217-23.
Available:https://doi.org/10.1001/jama.1996.03530270057032.

MacFadden DR, McGough SF, Fisman D, Santillana M, Brownstein JS. Antibiotic Resistance Increases with Local Temperature. Nat Clim Chang. 2018;8: 510-14.
Available:https://doi.org/10.1038/s41558-018-0161-6.

Blair JMA. A climate for antibiotic resistance. Nat Clim Change. 2018;8:460–61.
Available:https://doi.org/10.1038/s41558-018-0183-0.

Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4.
Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888801/.

Jia B, Raphenya AR, Alcock B, Waglechner N, Guo P, Tsang KK, et al. CARD 2017: Expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017;45:D566-D573.
Available:https://doi.org/10.1093/nar/gkw1004.

Achilli C, Ciana A, Minetti G. The discovery of methionine sulfoxide reductase enzymes: An historical account and future perspectives. Biofactors. 2015;41(3):135-52.
Available:https://doi.org/10.1002/biof.1214.

Singh VK, Singh K, Baum K. The role of methionine sulfoxide reductases in oxidative stress tolerance and virulence of Staphylococcus aureus and Other Bacteria. Antioxidants (Basel). 2018;7: E128.
Available:https://doi.org/10.3390/antiox7100128.

Singh VK, Jayaswal RK, Wilkinson BJ. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett. 2001;199(1):79–84.
Available:https://doi.org/10.1111/j.1574-6968.2001.tb10654.x.

Hauser AR, Mecsas J, Moir DT. Beyond antibiotics: New therapeutic approaches for bacterial infections. Clin Infect Dis. 2016;63(1):89-95.
Availabe:https://doi.org/10.1093/cid/ciw200

Raftery AE, Zimmer A, Frierson DMW, Startz R, Liu P. Less Than 2°C warming by 2100 unlikely. Nat Clim Chang. 2017;7: 637-41.
Available:https://doi.org/10.1038/nclimate3352.